LCT’s Board of Directors is responsible for the corporate governance of the consolidated entity. The Board guides and monitors the company’s business on behalf of the shareholders, by whom they are elected and to whom they are accountable.

LCT is implementing it's Corporate Governance Policy in accordance with the best practice recommendations of the ASX Corporate Governance Council. LCT adheres to the ASX / AusBiotech Code of Best Practice for Reporting by Life Science Companies, which was developed to enhance communication and understanding between companies and the investment community.